Targeted drug and radio therapies in oncology: from antibody to small molecule based therapeutics a.y. 2021/22

Programma

April 29^th, 2022, h. 10-13 - "From the discovery of Tumor-Targeting Ligands to the development of Drugs"
Dr. Samuele Cazzamalli (IUSS, Sala del Camino)
Introduction on basic concepts of tumor-targeting with antibodies and small organic compounds.

May 12^th, 2022, h. 9-12 - "Display Technologies for the discovery of targeting ligands: a focus on DNA-Encoded Chemical Libraries”
Dr. Gabriele Bassi (virtuale)
Introduction on DNA-encoded chemical libraries and their applications on the discovery of small organic ligands of proteins of pharmaceutical interest

May 19^th, 2022, h. 9-12 - "Antibody-Drug Conjugates and Small Molecule-Drug Conjugates"
Dr. Samuele Cazzamalli (virtuale)
Reviewing the pharmaceutical development of approved Antibody-Drug Conjugates and of advanced Small Molecule-Drug Conjugates for cancer therapy

June 9^th, 2022, h. 9-12 - "RadioImmuno-Conjugates and Small Molecule-Radio Conjugates" 
Dr. Samuele Cazzamalli (virtuale)
Reviewing the pharmaceutical development of advanced products based on RadioImmuno-Conjugates and Small Molecule-Radio Conjugates for cancer imaging and therapy.